Wai Chun Bio Technology Swings to HK$ 31.76 Million Profit for Year Ended June 30, 2026

PUBT · 1d ago
Wai Chun Bio Technology Swings to HK$ 31.76 Million Profit for Year Ended June 30, 2026
  • Wai Chun Bio-Technology's profit attributable to owners swung positive to HKD 7.21 million for the year ended June 30, 2026.
  • The turnaround primarily stemmed from a HKD 52.08 million reversal of impairment losses on property, plant and equipment.
  • Revenue rose 7% to HKD 404.63 million, supported by more customers and increased orders.
  • Net current liabilities narrowed 70% to HKD 51.53 million; auditors flagged material uncertainty over the group's ability to continue operating.
  • The group became Henan Mine Crane's exclusive overseas master agent for crane and mining equipment products outside mainland China in August.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wai Chun Bio Technology Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261113-12412994), on November 13, 2026, and is solely responsible for the information contained therein.